A carregar...
Targeting Oncogenic Mutant p53 for Cancer Therapy
Among genetic alterations in human cancers, mutations in the tumor suppressor p53 gene are the most common, occurring in over 50% of human cancers. The majority of p53 mutations are missense mutations and result in the accumulation of dysfunctional p53 protein in tumors. These mutants frequently hav...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4685147/ https://ncbi.nlm.nih.gov/pubmed/26732534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00288 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|